Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has amended the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback